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ProliferationThe retinoblastoma gene, RB-1, was the ﬁrst identiﬁed tumor suppressor. Rb−/− mice die in mid-gestation
with defects in proliferation, differentiation and apoptosis. The activating E2F transcription factors, E2F1–3,
contribute to these embryonic defects, indicating that they are key downstream targets of the retinoblastoma
protein, pRB. E2F4 is the major pRB-associated E2F in vivo, yet its role in Rb−/− embryos is unknown. Here
we establish that E2f4 deﬁciency reduced the lifespan of Rb−/− embryos by exacerbating the Rb mutant
placental defect. We further show that this reﬂects the accumulation of trophectoderm-like cells in both Rb
and Rb;E2f4mutant placentas. Thus, Rb and E2f4 play cooperative roles in placental development. We used a
conditional mouse model to allow Rb−/−;E2f4−/− embryos to develop in the presence of Rb wild-type
placentas. Under these conditions, Rb−/−;E2f4−/−mutants survived to birth. These Rb−/−;E2f4−/− embryos
exhibited all of the defects characteristic of the Rb and E2f4 single mutants and had no novel defects. Taken
together, our data show that pRB and E2F4 cooperate in placental development, but play largely non-
overlapping roles in the development of many embryonic tissues.© 2009 Elsevier Inc. All rights reserved.Introduction
The retinoblastoma protein, pRB, is a member of the family of
pocket proteins that includes p107 and p130. The most extensively
studied downstream effectors of the pocket proteins are the E2F family
of transcription factors (Attwooll et al., 2004; Dimova and Dyson, 2005;
Trimarchi and Lees, 2002). Both the pocket proteins and the E2Fs have
well deﬁned roles in regulating proliferation and differentiation during
development (McClellan and Slack, 2007; Wikenheiser-Brokamp,
2006). In particular, the interplay between the pocket proteins and
the E2Fs controls cell cycle exit and entry via the transcriptional
regulation of core components of the cell cycle machinery.
The E2F family is comprised of ninemembers, only six of which are
regulated by pocket protein binding. These six proteins play prefer-
ential roles in either the activation (E2F1, E2F2, E2F3A and B) or
repression (E2F4 and E2F5) of E2F target genes (Attwooll et al., 2004;
Dimova and Dyson, 2005; Trimarchi and Lees, 2002). The activating
E2Fs are speciﬁcally regulated by pRB in normal cells. In G0/G1 cells,
pRB binds to these E2Fs and suppresses their transcriptional activity.
Mitogenic signaling induces pRB phosphorylation by Cyclin/CDK
complexes, which causes the release of activating E2Fs, allowing
them to bind to and stimulate transcription of E2F-responsive genes.ogy, Stanford University School
arvard Medical School, Boston,
l rights reserved.The activating E2Fs drive S-phase progression when they are over-
expressed (Lukas et al., 1996; Muller et al., 1997) and cells that lack
these proteins have impaired proliferative capacity (Chonget al., 2009;
Danielian et al., 2008; Humbert et al., 2000b; Tsai et al., 2008;Wu et al.,
2001). The repressive E2Fs have distinct pocket protein binding
properties: E2F5 binds speciﬁcally to p130 in vivo, while E2F4
associates with pRB, p107 and p130 (Attwooll et al., 2004; Dimova
and Dyson, 2005; Trimarchi and Lees, 2002). E2F4 is the most
abundant E2F family member in vivo and it typically accounts for the
majority of the endogenous E2F-pocket protein complexes. In G0/G1
cells, E2F4 and E2F5 contribute to the active repression of E2F-
responsive promoters by recruiting large complexes that include the
pocket proteins and associated histone modifying enzymes (Blais and
Dynlacht, 2007). Mitogenic signaling causes dissociation of these
repressive complexes and released E2F4 and E2F5 translocate to the
cytoplasm. Consistent with their repressive roles, mouse embryo
ﬁbroblasts (MEFs) deﬁcient for E2F4 and E2F5 have no proliferation
defects, but they are unable to arrest in response to some growth
inhibitory signals (Gaubatz et al., 2000). Mouse models have shown
that E2f4 mutation causes a wide variety of developmental defects
including transient embryonic anemia and defective erythropoiesis
(Humbert et al., 2000a; Kinross et al., 2006; Rempel et al., 2000),
impaired commitment to the lymphoid lineage (Enos et al., 2008),
abnormal patterning of the ventral telencephalon (Ruzhynsky et al.,
2007), disrupted ossiﬁcation in some bones (E.S. Miller and J.A.L
unpublished observations), poor mammary gland development
(Andrechek et al., 2008), and loss of ciliated cells from the airway
epithelium (Danielian et al., 2007). In these cases E2F4 appears to have
functions both dependent and independent of cell cycle regulation.
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pRB in tumorigenesis and normal development (Burkhart and Sage,
2008; Wikenheiser-Brokamp, 2006). Rb+/− mice are predisposed to
develop tumors and this is dependent upon loss of the wild-type Rb
allele. Rb−/− embryos die in mid-gestation by E15.5 and exhibit
defective erythropoiesis in the fetal liver and widespread inappropri-
ate proliferation and apoptosis in the central nervous system (CNS)
peripheral nervous system (PNS) and ocular lens (Clarke et al., 1992;
Jacks et al., 1992; Lee et al., 1992;Macleod et al., 1996;Morgenbesser et
al., 1994). Germline and conditional mouse models have also revealed
a critical role for Rb in several developmental processes including
hematopoiesis and erythroid differentiation (Walkley et al., 2008),
skeletal muscle formation (Huh et al., 2004; Zacksenhaus et al., 1996),
and bone (Berman et al., 2008), skin (Ruiz et al., 2004; Wikenheiser-
Brokamp, 2004) and intestinal epithelium (Haigis et al., 2006; Yang
and Hinds, 2007) development.
Studies with chimeric and conditional animals have demonstrated
that the apoptosis in the CNS and a portion of the erythroid defects
arise as secondary consequences of a placental defect in Rb mutant
embryos (Wenzel et al., 2007; Wu et al., 2003). Speciﬁcally,
inappropriate proliferation of trophoblast stem cells in the labyrinth
layer of pRB-deﬁcient placentas results in a compaction of this layer
and decreased nutrient and gas exchange between the mother and
developing fetus. Consistent with this observation, the mid-gesta-
tional lethality of the Rb−/− mice is circumvented by the presence of
a wild-type placenta. Notably, analyses of both conditional and
chimeric Rb mutant mice show that ectopic proliferation in the lens,
CNS and PNS as well as abnormalities in erythrocyte maturation and
myogenesis are all cell-autonomous defects (de Bruin et al., 2003;
Ferguson et al., 2002; Lipinski et al., 2001; MacPherson et al., 2003;
Zacksenhaus et al., 1996).
The analyses of compound Rb;E2f mutant mice have shown that
the activating E2Fs contribute to many of the Rb mutant phenotypes.
First, mutation of either E2f1 or E2f3modulates the tumor phenotype
of the Rb+/−mice (Parisi et al., 2007; Yamasaki et al., 1998; Ziebold et
al., 2003). Second, germline mutation of E2f1, E2f2 or E2f3 is sufﬁcient
to extend the lifespan of Rb−/− embryos (Dirlam et al., 2007;
Saavedra et al., 2002; Tsai et al., 1998; Wenzel et al., 2007; Ziebold et
al., 2001). In this case, the individual E2Fs play somewhat different
roles. Mutation of E2f2 ameliorates many of the erythrocyte defects
(Dirlam et al., 2007). Loss of E2f1 or E2f3 has little effect on the
abnormalities in erythrocyte maturation or myogenesis, but greatly
suppresses both the apoptosis and proliferation defects in the Rb−/−
embryos, including the apoptosis that is attributed to the placental
defect. Furthermore, mutation of E2f3 in trophoblast stem cell lineage
suppresses the extra-embryonic defect of Rb mutants (Wenzel et al.,
2007). Taken together, these observations show that pRB-loss allows
E2F1 and E2F3 to induce inappropriate proliferation in extra-
embryonic tissues causing poor placental function, which leads to
apoptosis in the embryo proper.
We have focused our attention on the functional relationship of
pRB and E2F4, the major repressive E2F. We have previously shown
that the absence of E2F4 suppresses tumors in both Rb+/− mice and
Rb chimeras (Lee et al., 2002; Parisi et al., 2008). Although this seems
counter to the notion that E2F4 is a repressive E2F, there is some
evidence that E2F4 suppresses tumorigenesis through an indirect
mechanism (Lee et al., 2002). Given these observations, we wished to




Mixed (C57BL/6×129/Sv) background E2f4+/− and Rb+/−
mouse strains (Humbert et al., 2000a; Jacks et al., 1992) were usedto obtain germline Rb;E2f4 compound mutant embryos. The detection
of a vaginal plug was considered to be E0.5. Embryos were harvested
at the indicated times and viability was determined by the presence of
a heartbeat under a stereomicroscope. Tissues were ﬁxed in formalin
or 4% paraformaldehyde in phosphate buffered saline, embedded in
parafﬁn and sectioned at 4–6 μm. Sections were stained with
hematoxylin and eosin for histological analysis. The placental defect
was bypassed by breeding E2f4+/−, Rb2lox/2lox, and Meox2cre/+ strains
(Humbert et al., 2000a; Sage et al., 2003; Tallquist and Soriano, 2000).
Timed Rb2lox/2lox;E2f4+/−×Rb1lox/+;E2f4+/−;Meox2cre/+ crosses were
set up to obtain Rb1lox/1lox;E2f4−/−;Meox2cre/+ mice at the indicated
developmental ages. At E18.5, the ability to breathewas assessed upon
removal of the embryos from the yolk sac. Mice were ﬁxed in Bouin's
ﬁxative or formalin, embedded in parafﬁn and sectioned at 4–6 μm.
Sections were stained with hematoxylin and eosin for histological
analysis.
Immunohistochemistry and skeletal staining
For 5-bromo-2′-deoxyuridine (BrdU) incorporation analysis, preg-
nant mice were injected intraperitoneally with a BrdU and ﬂuor-
odeoxyuridine mixture 1 h prior to sacriﬁce. Staining for BrdU was
performed as previously described (Tsai et al., 2002) and hematoxylin
was used for counterstain. Terminal deoxynucleotidyltransferase-
mediated dUTP nick end labeling (TUNEL) assays were performed to
assess levels of apoptosis. Sections were deparafﬁnized, rehydrated,
blocked in 3% H2O2, treated with proteinase K, and incubated with
biotin-16-dUTP (Roche) and recombinant terminal deoxynucleotidyl-
transferase (Invitrogen). Biotin-dUTP was detected with ABC perox-
idase detection kit and DAB (Vector Labs). Methyl green was used for
counterstain. The number of BrdU- and TUNEL-positive nuclei over
the total number of nuclei in a given area was determined for 2–4
independent samples per genotype. Average values were then
adjusted relative to the percentages observed in Rb mutants, which
were set to 1. Quantiﬁcation of ectopically proliferating cells in the
CNS was determined by counting cells in the intermediate zone in the
hindbrains. Skeletal stainings were performed as previously described
(Humbert et al., 2000a).
In situ hybridization
In situ hybridizationwas performed on 4% paraformaldehyde (PFA)
ﬁxed, parafﬁn embedded sections. Sections were deparafﬁnized,
rehydrated, treated with proteinase K, reﬁxed with 4% PFA, incubated
in 2× SSC, dehydrated and air dried. Prehybridization was carried out
for 1 h followed by overnight hybridization with digoxygenin-labeled
riboprobes for Pl-1 (Colosi et al., 1987) and 4311/Tpbp (Lescisin et al.,
1988). Washes were done in 50% formamide/1× SSC/0.1% Tween-20
followed by washes in MABT (100 mM Maleic acid, 150 mM NaCl,
pH7.5, 0.5% Tween-20). Sections were blocked in 10% sheep serum/2%
blocking reagent (Roche) and then incubated with an anti-digox-
igenin antibody conjugated to alkaline phosphatase (Roche) at 4 °C
overnight. Sections were washed in MABT/levimasole (Sigma) and
BM purple (Roche) was used for detection.
Oligonucleotide microarray analysis and real-time PCR
Extra-embryonic tissues were separated from the maternal
deciduas under a stereomicroscope. Total RNA was prepared with
Trizol reagent (Invitrogen). RNA quality and concentration were
determined using an Agilent 2100 Bioanalyzer. For microarray
analysis, 2–3 biological replicates per genotype were used at E13.5
and at E11.5. Target preparation and hybridization to GeneChip®
Mouse Genome 430 2.0 arrays (Affymetrix) were performed
according to the manufacturer's instructions. The microarrays were
scanned with GeneChip® Scanner 3000 and images were analyzed
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normalized using the Affymetrix (1.20.0) and gcRMA 2.14.0;
bioconductor packages (Gentleman et al., 2004; Wu and Irizarry,
2004). The LPE test with Benjamini–Hochberg False Discovery Rate
correction was used for differential expression analysis (Benjamini
et al., 2001; Jain et al., 2003). Differential expression of a gene was
considered signiﬁcant if the adjusted p-valueb0.05 and the fold
change≥2.0. The microarray data were deposited in the Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under the
accession number GSE13753.
For real-time quantitative PCR analysis, cDNA synthesis was
performed using 2 μg total RNA and SuperScriptIII (Invitrogen). At
E13.5, 2–4 independently prepared samples were used per genotype
while at E11.5 3–4 biological replicates were tested per genotype.
qPCR reactions were carried out with 50 ng cDNA, 16 μM primers, and
SYBR Green PCR Master Mix in 20 μl total volume (Applied
Biosystems) in the ABI Prism 7000 Sequence Detection System.
Gene expression was normalized against ubiquitin expression. Primer
sequences are available upon request. For each gene, reactions were
performed 2–6 times per sample.
Results and discussion
Loss of E2F4 causes earlier lethality in Rb-deﬁcient mice
Over-expression and promoter occupancy studies strongly suggest
that the repressive E2F-pocket protein complexes play a critical role in
regulating the expression of E2F-responsive genes in G0 and early G1
phases of the cell cycle (Blais and Dynlacht, 2007). E2F4 typically
accounts for the majority of the endogenous pRB-, p107- and p130-
associated E2F activity in vivo and E2F4-loss has a profound effect on
the formation of pRB-deﬁcient tumors (Lee et al., 2002; Parisi et al.,
2008). To explore the interplay between E2F4 and pRB in normal
development, we intercrossed mixed C57BL/6×129/Sv background
Rb+/−;E2f4+/− mice to generate wild-type, Rb and E2f4 single and
double mutant embryos. We have previously shown that E2f4−/−
embryos are present at the expected frequency at all gestational stages
(Humbert et al., 2000a). Thus, we ﬁrst assessed embryo viability at
E13.5, the beginning of the window of lethality for Rb−/−mice (Table
1). Consistent with previous observations, Rb−/−micewere present at
the expected frequency and most, but not all, were alive as judged by
the presence of a heartbeat.We also detected Rb−/−;E2f4+/− embryos
at the expected Mendelian ratio, indicating that the loss of one E2f4
allele has no effect on the survival of Rb−/− animals at this
developmental stage. In contrast, the Rb−/−;E2f4−/− embryos (herein
referred to as DKO embryos) were clearly underrepresented at E13.5,
arising at approximately one-third of the expected frequency. There-
fore, the combined loss of pRB and E2F4 results in embryonic death
prior to E13.5.
To ascertain the timing of lethality for DKO embryos, we screened
for their presence at progressively earlier developmental stages (Table
1). At E11.5, DKO animals were detected at the expected frequency, but
only 54% (14 out of 26) were viable, as assessed by the presence of a
beating heart (Table 1). All of the other genotypes were present andTable 1
Mutation of Rb and E2f4 leads to embryonic lethality between E10.5 and E13.5.
Age Total # Rb−/−;E2f4+/+
Embryos obs (lv) exp
E13.5 201 14 (11) 13
E11.5 366 18 (15) 23
E10.5 386 27 (24) 24
E9.5 103 2 (2) 6
Frequency of embryos arising from Rb+/−;E2f4+/− intercrosses. Only embryos homozygous f
or morphology), exp=expected number.alive at the expected frequency, reinforcing our conclusion that E2F4-
loss reduces the lifespan of Rb−/− embryos. At E10.5, an increased
proportion (68%, 13 out of 19) of DKO embryos had a detectable
heartbeat and at E9.5 viable DKOs were present at the expected
frequency. Embryos at E12.5 were not examined as already at E11.5
only one half of the DKOs were viable (approximately 1 in 30
embryos). Therefore, the DKO embryos die between E10–E14, which is
signiﬁcantly earlier than Rb−/− embryos (E13.5–E15.5).
Given the clear shift in the window of lethality of DKO versus Rb−/−
embryos we conducted careful analyses of these embryos. By gross
morphological and histological examination, DKO embryos displayed
the same spectrum, and similar severity of defects that had been
previously reported for the single homozygous mutants. E13.5 Rb−/−
and E2f4−/− embryos both appear paler than their wild-type littermate
controls as a result of their respective erythrocyte differentiation defects
(Humbert et al., 2000a; Jacks et al., 1992) and DKO embryos had a
similar pallid coloration. Furthermore, DKO embryos were smaller than
littermate controls as previously reported for the E2f4mutants (Fig. 1A)
(Humbert et al., 2000a; Rempel et al., 2000). Therefore, apart from the
characterized Rb−/− and E2f4−/− phenotypes, the DKOs did not display
any additional morphological defects.
It is well established that the E13.5 Rb−/− embryos exhibit striking
levels of inappropriate S-phase entry and apoptosis in the lens, CNS
and PNS (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992; Macleod
et al., 1996; Morgenbesser et al., 1994). Therefore we used BrdU
incorporation and TUNEL assays to determine whether the levels of
ectopic cellular proliferation and apoptosis, respectively, were
exacerbated in DKO embryos (Fig. 1B–E; data not shown). Since a
signiﬁcant fraction of DKO embryos are dead by E13.5, we assayed S-
phase entry in E11.5 embryos. In the lens vesicles, we detected a
similar high level of BrdU-positive cells in all genotypes (Fig. 1D). This
is consistent with the fact that the lens is actively developing at E11.5
and cells are only just beginning to exit the cell cycle (Kaufman et al.,
1995). In contrast, Rb−/− embryos had increased levels of BrdU-
positive cells in the intermediate zone of the hindbrain (CNS) and the
dorsal root ganglia (PNS) compared to control and E2f4−/− embryos
(Fig. 1B and D; data not shown). This elevated proliferation occurred
at a similar level in Rb−/− and DKO embryos (Fig. 1B and D) indicating
that E2F4 does not modulate the inappropriate proliferation that
arises in pRB-deﬁcient embryos.
We also assessed the levels of apoptosis in the developing
embryos. At E11.5, we detected a similar, subtle increase in apoptotic
cells in the hindbrains of both Rb−/− and Rb−/−;E2f4−/− embryos
relative to control littermates (data not shown). This apoptosis defect
was more pronounced at E13.5 (Fig. 1C and E). As previously
reported, Rb−/− embryos displayed high levels of programmed cell
death in the hindbrain near the fourth ventricle (CNS), the trigeminal
ganglia (PNS) and the ocular lens. We observed a similar level of
apoptosis in each of these tissues in the Rb−/−;E2f4−/− embryos
(Fig. 1E). Taken together, these data suggest that E2f4-loss does not
exacerbate either the inappropriate proliferation or apoptosis arising
in the Rb−/− embryos. Thus, increased cell death in these embryonic
tissues does not contribute to the reduced survival of the DKO versus
the Rb−/− embryos.Rb−/−;E2f4+/− Rb−/−;E2f4−/−
obs (lv) exp obs (lv) exp
26 (24) 25 4 (3) 13
49 (46) 46 26 (14) 23
53 (43) 48 19 (13) 24
15 (13) 13 9 (7) 6
or the Rbmutation are shown. obs=observed number, lv=live (as judged by heartbeat
Fig. 1. E2F4-loss does not affect inappropriate proliferation and apoptosis in the Rb−/− embryos. (A) Control, Rb−/− and Rb−/−;E2f4−/− embryos at E11.5. (B) BrdU incorporation shows
that S-phase cells are restricted to the ventricular zone of the hindbrain in control embryos, but are also present in the intermediate zone in Rb−/− and Rb−/−;E2f4−/− embryos at E11.5
(40× magniﬁcation). (C) TUNEL staining shows similar levels of apoptotic cells in the hindbrains of Rb−/− and Rb−/−;E2f4−/− at E13.5. Quantitation of BrdU-positive (D) and TUNEL-
positive (E) cells in control and mutant animals at E11.5 and E13.5, respectively, in the PNS (trigeminal ganglia), CNS (hindbrain) and ocular lens. Loss of E2F4 has no effect on the levels
of proliferating and apoptotic cells in Rb mutant embryos. All data are represented relative to the percentages observed in Rb mutants (+standard deviation), which were set to 1.
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Since our embryonic analyses did not provide any cause for the
early lethality of the DKO animals, we next examined the extra-
embryonic tissues. pRB-loss causes hyperproliferation of trophoblast
cells in the labyrinth layer of the placenta, leading to reduced
nutrient and gas delivery to the embryo (Wenzel et al., 2007; Wu et
al., 2003). Consistent with these reports, the labyrinth layer defect
was highly penetrant in our E13.5 Rb−/− embryos (Fig. 2A and B). At
earlier timepoints, E10.5 and E11.5, this defect was only apparent in a
small subset of Rb−/− embryos and was extremely subtle (data not
shown). At E11.5 no signiﬁcant morphological defect was observed inE2f4−/− placentas in comparison with wild-type placentas (Supple-
mentary Fig. 1, data not shown). Histological examination at E11.5
showed that E2F4-loss enhanced the labyrinth layer defect in the Rb-
deﬁcient background but had no discernable effect on the other
placental layers (Fig. 3B). Speciﬁcally, the size of the labyrinth layer
relative to the entire placenta was reduced in the DKO placentas
when compared with that of the wild-type control extra-embryonic
tissues (Fig. 3B). Quantiﬁcation of the labyrinth layer reduction at
E11.5 indicated a statistically signiﬁcant reduction (16%, p=0.015) in
the DKO embryos relative to the wild-type control (Supplementary
Fig. 1). At this same timepoint, the Rb−/− placentas displayed a
smaller reduction (9.3%) that was not statistically signiﬁcant
Fig. 2. The placental defect in Rb−/− embryos is exacerbated in Rb−/−;E2f4−/− embryos at E13.5. Representative hematoxylin and eosin stained placental sections of control and
mutant littermates at a magniﬁcation of 10× (A) and 20× (B); the bar in each panel corresponds to 100 μm. The loss of Rb results in a denser labyrinth layer (L) compared to the
control. In the Rb−/−;E2f4−/− placentas, this layer is further compacted and reduced in size. (C) In situ hybridization for 4311 (Tpbp) indicates that the spongiotrophoblast layer (Sp)
is relatively normal in the mutant placentas. Magniﬁcation, 10×. MD, maternal decidua; C, chorionic plate.
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mutants were typically not well vascularized (Fig. 3A) at this stage.
The synergy between pRB- and E2F4-loss was even more
pronounced at E13.5 (Fig. 2A and B). Every Rb−/−;E2f4−/− placenta
examined had a smaller and more compacted labyrinth layer than
the Rb−/− placentas (Fig. 2A and B; data not shown). This clearly
reﬂects synergy between E2f4 and Rb in placental function as the
E2f4 single mutants had no detectable morphological differences
and the height of the labyrinth layer, relative to the total placenta
(average±S.D.=50±15%) was not signiﬁcantly different from
wild-type controls at E13.5 (54.2±5.6%, p=0.577; data not
shown) or E11.5 (Supplementary Fig. 1). Taken together, these
data show that E2F4-loss aggravates the labyrinth layer defect in
Rb−/− placentas, strongly suggesting that the early lethality of DKO
versus Rb−/− embryos results from an exacerbation of the placental
insufﬁciency.
To determine whether the reduction or compaction of the
labyrinth layer was a result of changes in cell division, we used BrdU
incorporation to compare the levels of proliferation in the mutant
placentas. This analysis was conducted at E11.5, in large part, because
viable DKO embryos are well represented at this stage. Although the
labyrinth defect was clearly apparent in E11.5 DKO placentas, we
observed a similar, high percentage of proliferating cells in DKO,
Rb−/− and control labyrinth layers (data not shown). This highproliferative index likely reﬂects the active development of the
labyrinth at E11.5. Unfortunately, the rarity of viable DKO embryos
at later developmental stages precluded comparison of BrdU
incorporation in Rb−/− versus DKO placentas at E13.5. We screened
E11.5 placentas for apoptosis and found no difference in the levels of
TUNEL-positive cells between wild-type, Rb−/−, and DKO placentas
(data not shown). Thus, the enhanced labyrinth defect observed in
DKO versus Rb−/− animals at E11.5 does not result from any detectable
change in the levels of proliferation or apoptosis in this tissue.
We also examined the expression levels of representative placental
layer-speciﬁc differentiation markers at E11.5 and E13.5 using a
combination of in situ hybridization and quantitative real-time PCR
(qPCR). There was no signiﬁcant difference in the expression levels/
pattern of the spongiotrophoblast markers 4311/Tpbp (Figs. 2C and
3C) and/or ﬂt1 (Fig. 4A and B) between control, Rb−/− and DKO
placentas at either timepoint. Similarly, the trophoblast giant cell
markers placental lactogen-1 (Figs. 3D, 4A and B) and proliferin-1
(data not shown) were expressed at comparable levels in DKO, Rb−/−
and control littermates. Together with the hematoxylin and eosin
staining of the placentas, these data show that the trophoblast giant
cell and spongiotrophoblast layers are not appreciably affected by the
loss of E2F4 and/or pRB. Finally, we examined the expression of Esx-1,
a marker of differentiated labyrinth trophoblasts, at E11.5 and E13.5
(Fig. 4A and B). Remarkably, despite the aberrant morphology of the
Fig. 3. Loss of E2F4 aggravates the placental defect in Rb−/− embryos at E11.5. (A) Control yolk sacs are highly vascularized while there is a decrease in the number of blood vessels in
the Rb mutant yolk sacs. Loss of E2F4 further impairs vascularization in the yolk sac. (B) Hematoxylin and eosin stained placental sections of control and mutant littermates at a
magniﬁcation of 10×; the bar in each panel represents 100 μm. In Rb−/−;E2f4−/− placentas the height of the labyrinth layer is reduced. (C) In situ hybridization for 4311 (Tpbp)
indicates that the spongiotrophoblast layer (Sp) is relatively unaffected in the mutant placentas. Magniﬁcation, 10×. (D) Trophoblast giant cell differentiation is largely unaffected in
mutant placentas as assessed by in situ hybridization for placental lactogen-1. Magniﬁcation, 2×. ⁎Position of trophoblast giant cells; MD, maternal decidua; C, chorionic plate; ET,
embryonic tissue.
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difference in the expression of Esx-1 relative to littermate controls.
Thus, the compaction of the labyrinth layer in Rb−/− or DKO placentas
is not associated with increased expression of differentiated labyrinth
trophoblast markers.
Expression proﬁle of mutant placentas
We hypothesized that the placental defect would be associated
with gene expression changes, either as a direct result of the loss of the
transcriptional properties of E2F4 and/or pRB or as a downstream
consequence. To better understand the molecular basis of the defect,
we used Affymetrix whole mouse genome (430 2.0) microarrays to
compare the gene expression proﬁles of control and mutant extra-
embryonic tissues. We began by comparing wild-type and Rb−/−
placentas at E13.5, the timewhen the placental defect is evident in the
majority of Rb−/− samples. After excluding sex-linked genes, this
screen identiﬁed 236 genes that were differentially expressed
between wild-type and Rb−/− replicates with a ≥2-fold difference
in expression level and an adjusted p-valueb0.05. Of these genes, 107
were down-regulated and 129 were up-regulated by the inactivation
of Rb (Fig. 5; Supplemental Tables 1 and 2). Rb was identiﬁed as a
repressed gene, providing validation for the array analysis.
Consistent with the prevailing view that pRB-loss promotes E2F
transcriptional activity, a subset of the induced genes are known E2F
target genes. To further validate these ﬁndings, we performed qPCR onrepresentative E2F-responsive genes, mcm2, mcm3, mcm6, mcm7, cy-
clin E1, cyclin E2 and E2f1. All seven of these targets were signiﬁcantly
up-regulated in Rb−/− placentas at E13.5 (Fig. 6A; data not shown).
These results are consistent with the previous report of inappropriate
proliferation in pRB-deﬁcient placentas at this timepoint (Wu et al.,
2003). Given the success of the Rb mutant analysis, we extended our
studies to compare the gene expression proﬁles of DKO placentas and
wild-type controls. For this analysis, we used E11.5 samples due to the
difﬁculty in recovering viable DKO embryos at E13.5. At this earlier
stage 35 genes (17 down-regulated and 18 up-regulated) were
signiﬁcantly deregulated in the E11.5 DKO placentas (Fig. 5; Supple-
mental Tables 3 and 4). As an internal control for this array
experiment, Rb was identiﬁed as a down-regulated gene. (E2f4
expression was also down-regulated although this did not reach
statistical signiﬁcance). By comparing our array results from the DKO
placentas with those from the Rb−/− placentas we identiﬁed 2/17 of
the down-regulated genes (Rb and B430119L13Rik) and 3/18 of the
up-regulated genes (Dppa5, Tsc22d, Bzw2) in common between the
two sets of experiments. Deregulation of these genes is likely to be
important for the placental defect.
We presume that the relatively small number of differentially
expressed genes identiﬁed in DKO (n=35) versus Rb−/− (n=236)
placentas reﬂects the different timing of the analyses (E11.5 and E13.5,
respectively) and that the 35 genes constitute the earliest detectable
expression changes that coincide with the emerging placental defect.
Notably, while E2F-responsive genes were induced genes in E13.5
Fig. 4. Placental layer-speciﬁc markers are unchanged in mutant placentas. At E13.5 (A)
and E11.5 (B) wild-type and mutant placentas expressed equivalent levels of placental
lactogen-1 (Pl-1, trophoblast giant cell layer marker), Flt-1 (spongiotrophoblast layer
marker), and Esx-1 (labyrinth layer marker), as assessed by quantitative real-time PCR.
Gene expression levels are normalized to ubiquitin expression levels. Standard
deviation is represented by the error bars.
Fig. 5. Microarray data analysis identiﬁes common genes deregulated in Rb−/− and
Rb−/−;E2f4−/− placentas at E13.5 and E11.5. At E13.5, microarray analysis was used to
determine which genes are deregulated in Rb−/− placentas in comparison with wild-
type placentas. At E11.5, Rb−/−;E2f4−/− placental cDNA was compared with wild-type
placental cDNA. Comparison of the deregulated gene sets identiﬁed common sets of
up- and down-regulated genes including Dppa5 (a marker of pluripotent cell types)
and Rb, respectively.
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or down-regulation) of E2F-responsive genes inDKOplacentas at E11.5
(Fig. 6B; Supplemental Tables 3 and 4). To further explore this ﬁnding,
we used qPCR to screen E11.5 placentas from wild-type, E2f4−/−,
Rb−/− and DKO embryos for four classic E2F-responsive genes
(mcm2, mcm6, cyclinE1 and cyclinE2) that were clearly up-regulated
in the E13.5 placentas from Rb−/− embryos (Fig. 6A). We observed
a modest induction of cyclinE2 in the DKO and Rb−/− placentas
(p-values of 0.1 and 0.01, respectively). The other three genes were
expressed at similar levels in the control versus Rb−/− or DKO
E11.5 placentas. These ﬁndings are entirely consistent with our
BrdU labeling studies, which detected a difference in the level of
proliferating cells in Rb mutant versus wild-type placentas at E13.5,
but not at E11.5.
Given these observations, we focused our attention on the list of
genes that were deregulated in DKOs. The most striking was a gene
named developmental pluripotency associated 5 (Dppa5) or embry-
onal stem cell-speciﬁc gene 1 (Esg-1). Dppa5/Esg-1 was one of the
three genes induced in both DKO and Rb−/− placentas (Fig. 5,
Supplemental Tables 1 and 3). In both comparisons, Dppa5 probes
report a N8-fold increase in expression in the mutant placentas with
adjusted p-values of approximately zero. Dppa5/Esg-1 was originally
identiﬁed as a gene expressed in embryonal carcinoma cells and
embryonic stem (ES) cells, but not in lineage-committed stem cells
such as trophoblast stem (TS) cells, or somatic cells (Astigiano et al.,
1991; Bierbaum et al., 1994). This led to the initial conclusion that
Dppa5/Esg-1 was an ES cell-speciﬁc marker. Subsequent studies,
however, have shown that Dppa5/Esg-1 is also expressed in thetrophectoderm, a TS cell precursor, and germ cells (Ahn et al., 2004;
Bortvin et al., 2003; Tanaka et al., 2002). Quantitative real-time PCR
conﬁrmed our microarray data; Dppa5 mRNA levels were induced 10
fold in Rb−/− placentas at E13.5 and approximately 4-fold in both
Rb−/− and DKO placentas at E11.5 relative to age matched controls
(Fig. 6C and D). Previous studies concluded that the placental in-
sufﬁciency of the Rb mutants results from the uncontrolled prolifera-
tion of trophoblast stem cells within the labyrinth layer (Wenzel et al.,
2007; Wu et al., 2003). This was based on detection of increased
expression of Eomes, a knownmarker of TS cells. Contrary to thisﬁnding,
we did not observe any signiﬁcant difference in Eomes expressionwhen
comparing Rb−/− and/or DKO placentas with wild-type controls at
E11.5 and E13.5, as judged by microarray and qPCR (Fig. 6C, D
Supplemental Tables 1–4). In accordance with a prior report (Tanaka
et al., 2002), we ﬁnd that Dppa5/Esg-1 is expressed in wild-type
trophectoderm, but not in TS cells (data not shown). Thus, taken
together, our data suggests that the loss of pRB causes an increase in the
numbers of trophectoderm-like cells at E11.5 and this contributes to the
increased cellularity of the labyrinth layer, which ultimately results in
placental insufﬁciency. The further induction of Dppa5/Esg-1 and the
detectable increase of cell cycle gene expression at E13.5 suggests that
the trophectoderm-like cells are proliferating inappropriately and this
may account for theprogressiveworseningof the placental defect at this
later developmental stage.
Early lethality is rescued in conditionally mutant animals
To determine whether the placental defect is the primary cause of
death of the DKO embryos, we generated a conditional mouse model
in which DKO embryos were provided with Rb+/+ placentas. Using
the strategy employed byWu et al., (2003), we interbred the E2f4+/−
mice with a conditional Rb mutant strain, Rb2lox/2lox (Sage et al.,
2003), and an epiblast-speciﬁc Cre line, MORE (Meox2-Cre) (Hayashi
et al., 2002; Tallquist and Soriano, 2000). Cre recombinase expression
from theMeox2 promoter is detected in the embryo proper by E6, but
themajority of extra-embryonic tissues do not express Cre (Hayashi et
al., 2002; Tallquist and Soriano, 2000). Thus, through comparative
analysis of Rb1lox/1lox;Meox2cre/+ and Rb1lox/1lox;E2f4−/−;Meox2cre/+
embryoswe can determinewhether the early lethality associatedwith
the loss of both pRB and E2F4 is due to the aggravated placental defect.
For simplicity, we will refer to these conditional mutant embryos as
cRb−/− and cRb−/−;E2f4−/−.
As previously reported (de Bruin et al., 2003; Wu et al., 2003),
cRb−/− mice were dead at birth. We also recovered inviable cRb−/−;
E2f4−/− animals at this timepoint (data not shown). Irrespective of
their E2f4 genotype, the cRb−/− embryos were present at less than
the expected frequency. Since this under-representation could be due
to the cannibalism of dead or unhealthy newborns, we used timed
Fig. 6. E2F-target genes andDppa5 expression are deregulated inRb andRb;Ef24mutant placentas. (A) Cell cycle genes are expressed at increased levels in E13.5Rb−/− placentas compared
to wild-type placentas. (B) At E11.5, wild-type and mutant placentas express cell cycle genes at similar levels. Expression of Eomes (a trophoblast stem cell marker) and Dppa5
(a pluripotency marker) in wild-type and mutant placentas at E13.5 (C) and E11.5 (D). Eomes is expressed at similar levels among the various genotypes whilst Dppa5
expression is signiﬁcantly elevated in Rb−/− and Rb−/−;E2f4−/− placentas. Gene expression levels are normalized to ubiquitin expression levels and error bars represent
standard deviation.
Table 2
Conditional mutation of Rb allows survival of cRb−/−;E2f4−/− embryos up to E18.5.
Age Total # cRb−/−;E2f4+/+ cRb−/−;E2f4+/− cRb−/−;E2f4−/−
Embryos obs exp obs exp obs exp
E18.5 258 19 16 39 32 12 16
E15.5 100 6 6 15 12 4 6
E13.5 65 6 4 9 8 5 4
Frequency of embryos arising from Rbc/c;E2f4+/−× cRb+/−;E2f4+/−;Meox2+/cre
intercrosses. Only Meox2+/creembryos shown. obs=observed number, exp=expected
number.
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embryos in utero. cRb−/− embryos, regardless of their E2f4 status,
were present and alive at the expected frequency at E13.5, E15.5 and
immediately prior to birth (E18.5), as judged by the presence of a
heartbeat (Table 2). At E18.5 the cRb−/− and cRb−/−;E2f4−/− embryos
died once they were removed from the uterus, because they could not
begin or sustain breathing (data not shown). Thus, the presence of an
Rb wild-type placenta allows cRb−/− and cRb−/−;E2f4−/− embryos to
survive up to, but not beyond, birth. This is deﬁnitive proof that the
reduced lifespan of the germline DKO embryos (E10–E14) is directly
related to the increased severity of the placental defect.
E2F4 and pRB play largely independently roles in embryonic
development
Since cRb−/− and cRb−/−;E2f4−/− mutant mice survive beyond
E13.5, wewere able to determine the consequences of E2F4- and pRB-
deﬁciency on later stages of embryonic development. Initially we
veriﬁed the efﬁciency of Cre recombination by showing that pRB was
no longer detectable in mouse embryonic ﬁbroblasts generated from
cRb−/− or cRb−/−;E2f4−/− embryos (data not shown). Then we
conducted a careful comparison of the single and double Rb/E2f4
mutants. In a similar manner to the germline mutant embryos, we
found that cRb−/−;E2f4−/− embryos exhibited a pattern of defects
that phenocopied those present in E2f4−/− and cRb−/− littermate
controls. These phenotypes were detected at E13.5 and continued to
birth. Fig. 7 shows defects that were present at E18.5. At a gross
morphological level, E18.5 cRb−/−;E2f4−/− animals displayed the
pallid coloration and reduced size and weight that was characteristicof their E2f4−/− littermates (Fig. 7A; data not shown). In addition,
cRb−/−;E2f4−/−mutants had the same hunched appearance as cRb−/−
single mutants that results from an alteration in the curvature of the
spine (Fig. 7A andB). The cRb−/− and cRb−/−;E2f4−/−mutants also had
misshapen ribs andabsence of amuscle attachment site on thehumerus,
both known consequences of abnormal musculature (Fig. 7B; data not
shown). Histological inspection conﬁrmed that cRb−/− and cRb−/−;
E2f4−/− embryos had a reduced muscle density that was associated
with myoblast apoptosis (as assessed by TUNEL staining), shortened
myotubes, and reduced muscle ﬁbers in the skeletal muscle, including
the intercostal, forelimb and hindlimb muscles (Fig. 7C; data not
shown).
Germline inactivation of Rb leads to ectopic S-phase entry and
increased programmed cell death in the lens of the eye and the
nervous system (Lee et al., 1992;Macleod et al., 1996;Morgenbesser et
al., 1994). The unscheduled proliferation associated with pRB-loss is
cell-autonomous; however, the apoptosis observed in the nervous
system, but not in the lens, is largely due to the placental defect in
Fig. 7. Conditional Rb−/−;E2f4−/− embryos exhibit Rb and E2f4 mutant phenotypes at E18.5. A) Control, E2f4−/−, Rb1lox/1lox;Meoxcre/+ (cRb−/−) and Rb1lox/1lox;E2f4−/−;Meoxcre/+
(cRb−/−; E2f4−/−, cDKO) embryos at E18.5. cDKO embryos are growth retarded, like E2f4−/−mice, and have a hunched appearance similar to cRb−/− embryos. B) Skeletal staining
with Alcian blue (cartilage) and Alizarin red (bone) of control and mutant embryos reveals altered curvatures of the spine and ribcage in the cRb−/− and cDKO embryos. C) Decrease
in muscle density and ﬁber organization in the Rbmutants is unchanged with the additional loss of E2F4 as judged by hematoxylin and eosin staining. Magniﬁcation, 40×. D) Darkly
stained BrdU-positive cells were detected in the lens ﬁber cell compartment (indicated by the black arrows) in the cRb−/− and cDKO lenses, but not in the control and E2f4−/−
lenses. Magniﬁcation, 40×. E) Giemsa stained peripheral blood smears from control and mutant animals. There are a considerable percentage of erythroblasts containing Howell–
Jolly bodies (white arrowheads) following the loss of E2F4while the loss of pRB leads to a number of immature nucleated erythroblasts (black arrowheads). Both of these phenotypes
are present in cDKO blood preparations.
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participates in cell cycle control and cell survival associated with
pRB, we analyzed the levels of proliferation and apoptosis in the
rescued double mutant animals. Through analysis of incorporated
BrdU, we showed that there was a considerable degree of ectopic
proliferation in both the ocular lens and hindbrain of E18.5 cRb−/−;
E2f4−/− embryoswhich closely paralleled that observed in the cRb−/−
controls (Fig. 7D; data not shown). We also detected a comparable
level of apoptosis in the lenses of cRb−/−;E2f4−/− and cRb single
mutant embryos at E18.5 (data not shown). Finally, we observedsigniﬁcant levels of TUNEL-positive cells in the retina of cRb−/−
mutants and the concomitant loss of E2F4 had no effect on this
phenotype (data not shown). Thus, in concordance with our analyses
of the germline DKO embryos, E2F4-loss had no inﬂuence on the levels
of ectopic proliferation and apoptosis in cRb−/− embryos, showing
that E2F4-loss does not impact these pRB-regulated processes. This
also suggests that E2F4–p107 and E2F4–p130 complexes are unable to
compensate for the loss of pRb in these tissues during development.
E2F4 and pRB each have demonstrated roles in erythroid diffe-
rentiation. E2f4−/− embryos exhibit severe fetal anemia from E13.5 to
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al., 2000). Analysis of peripheral blood smears reveals a signiﬁcant
proportion of abnormal erythrocytes, including nucleated erythro-
cytes and cells containing Howell–Jolly bodies, which are remnants of
chromatin that have not been completely extruded during enucleation
(Humbert et al., 2000a; Kinross et al., 2006). Rb−/− embryos also have
a pale appearance, reduced cellularity in the fetal livers and an increase
in immature nucleated erythrocytes (Clarke et al., 1992; Jacks et al.,
1992; Lee et al., 1992). Analyses of conditional and chimeric mutant
mice show that the red blood cell (RBC) defect in Rb−/− animals
results from both non cell-autonomous and cell-autonomous effects
(Clark et al., 2004; de Bruin et al., 2003; Dirlam et al., 2007;Maandag et
al.,1994; Sankaran et al., 2008; Spike et al., 2004;Williams et al.,1994).
E2F4 and pRB are both required for normal RBC development, but
their epistasis is unknown. We therefore analyzed peripheral blood
from the E18.5 conditional embryos to determine whether the RBC
defects arising in the pRB mutant embryos are modulated by the loss
of E2F4, or vice versa. Consistent with previous ﬁndings, E2f4−/−
embryos were anemic at E18.5, as evidenced by a 30% reduction in
hematocrit levels compared to those of wild-type littermates (p-
valueb3×10−6; Fig. 8A). The cRb−/− embryos had a similar decrease
in hematocrits (p-valueb0.02), supporting the observation that pRB-
loss has a signiﬁcant effect on erythrocyte development. We foundFig. 8. Anemia and morphological red blood cell defects in cRb−/− and E2f4−/−
embryos are additive in cRb−/−;E2f4−/− embryos. (A) Hematocrit analyses of blood
from E18.5 embryos of the indicated genotypes. Each dot represents one embryo and
the mean is indicated by a horizontal bar. In comparison with wild-type embryos both
the cRb−/− and E2f4−/− embryos display reduced levels of red blood cells and the
effect is compounded in the double mutants. (B) Quantiﬁcation of the percentage of red
blood cells displaying failed enucleation or Howell–Jolly bodies, which are character-
istic phenotypes of cRb−/− and E2f4−/− embryonic erythrocytes at E18.5, respectively.
There is an additive effect in double mutant embryos. The error bars represent one
standard deviation from the mean.that there was a further decrease (∼60%) in hematocrits of cRb−/−;
E2f4−/− embryos relative to wild-type embryos (p-valueb5×10−6).
Cytological investigation of the peripheral blood cells at E18.5
revealed that cRb−/−;E2f4−/− embryos displayed the additive
phenotypes of the cRb−/− and E2f4−/− mice (Figs. 7E and 8B).
Consistent with previous studies, most of the RBCs in E18.5 wild-type
embryos were mature enucleated erythrocytes and we rarely
observed immature nucleated RBCs (0.02%±0.05) or mature ery-
throcytes containing Howell–Jolly bodies (0.42%±0.13). In cRb−/−
embryos, we observed a more than 80-fold higher level of immature
nucleated RBCs (1.7%±1.03) and therewas also a small increase in the
proportion of RBCs with Howell–Jolly bodies (0.9%±0.33). In
contrast, E2f4−/− embryos showed a less dramatic increase in the
level of immature nucleated RBCs (0.41%±0.12), but there was a large
elevation in the fraction of RBCswith Howell–Jolly bodies (5.1%±2.7).
Remarkably, cRb−/−;E2f4−/− embryos had a high proportion of both
immature nucleated erythrocytes (2.8%±1.4) and RBCs with Howell–
Jolly bodies (6.3%±2.3) that was essentially additive of the cRb−/−
and E2f4−/− mutant phenotypes. In line with this ﬁnding, E2F4 and
pRB showmutually exclusive occupation of E2F-responsive promoters
in E15.5 fetal liver cells (Dirlam et al., 2007). These observations show
that pRB and E2F4 play important and independent roles in
embryonic erythroid development.
In toto, our analyses show that cRb−/−;E2f4−/− embryos display
all of the defects of the cRb−/− and E2f4−/− single mutants without
any detectable increase in severity or evidence of new phenotypes. In
consideration of this, and our analysis of the germline Rb;E2f4
mutants, we conclude that E2F4 and pRB play distinct roles in the
development of embryonic versus extra-embryonic tissues. In the
former setting, E2F4 and pRB appear to function largely indepen-
dently from one another. This ﬁnding was somewhat surprising, given
that E2F4 is the predominant pRB-associated E2F in most cell types,
including embryonic ﬁbroblasts. It remains to be established whether
the non-overlapping roles of E2F4 and pRB result from their
differential regulation of speciﬁc E2F-responsive genes, as suggested
by chromatin immunoprecipitation studies in fetal liver cells (Dirlam
et al., 2007), or whether they reﬂect broader roles for E2F4 and/or
pRB. In support of the latter hypothesis, E2F4 and pRB have both been
shown to function as co-factors for other transcriptional regulators
(Chen et al., 2002; Hansen et al., 2004; Scime et al., 2005; Thomas et
al., 2001). In contrast to the embryonic tissues, E2F4 and pRB clearly
act synergistically in extra-embryonic tissues by promoting normal
development of the labyrinth layer of the placenta. Our data strongly
suggest that the placenta defect in both Rb−/− and DKO mutants
reﬂects the inappropriate persistence of trophoectoderm-like cells.
Speciﬁcally, expression proﬁling of the mutant placentas shows an
increase in levels of Dppa5 mRNA, a marker of early trophoectoderm
but not trophoblast stem cells. Dppa5 upregulation is clearly
detectable at E11.5, whenwild-type, Rb−/− and DKO extra-embryonic
tissues show a similar, high degree of proliferation. There are no
consensus E2F binding sites within the upstream sequences or ﬁrst
intron of the Dppa5 gene (data not shown) suggesting that an indirect
mechanism results in increased Dppa5 mRNA levels in pRb−/− and
DKO placentas; for example, an increase in the trophoectoderm-like
cell population within the placenta. High Dppa5 mRNA levels persist
at E13.5, and are accompanied by an upregulation of E2F-responsive
mRNAs and inappropriate proliferation in both the Rb−/− and DKO
placentas. Given these observations, we hypothesize that pRB-loss
impairs the development of the labyrinth layer by promoting
proliferation, and presumably impeding differentiation, of the
trophoectoderm-like cells. Loss of E2F4 exacerbates the placental
phenoytpe, leading to an earlier disruption of placental function and
the concomitant failure of embryonic development. It is interesting to
note that Rb−/−;p107−/− embryos also die a couple of days earlier
than Rb−/− embryos (Lee et al., 1996), similar to the Rb−/−;E2f4−/−
embryos. The study of Rb−/−;p107−/− embryos was conducted before
114 E.Y. Lee et al. / Developmental Biology 332 (2009) 104–115pRB's role in placental development was discovered, and the extra-
embryonic tissues were not examined. However, since the extra-
embryonic defect accounts for the mid-gestational lethality of the Rb
mutants, the shortened lifespan of the Rb−/−;p107−/− embryos may
reﬂect an exacerbation of the Rb mutant placental defect. Further-
more, we can detect E2F4–p107/p130 complexes in E11.5 placental
extracts by immunoprecipitation experiments but were unable to
detect E2F4–pRB complexes due to the low amounts of pRB in this
tissue (data not shown). It is well established that E2F4 and p107 act
together to mediate the repression of E2F-responsive genes (Balciu-
naite et al., 2005). Together with our observation that known E2F-
responsive genes are deregulated in Rb−/− and Rb−/−;E2f4−/−
placentas this strongly suggests that the synergy between E2F4 and
pRB in placental development reﬂects the shared roles of these
proteins, and likely p107, in regulating the transcription of these
genes.
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